C0042210||vaccine
C0017446||Kano
C0028075||Nigeria
C0042210||vaccine
C0015264||redesign efforts
C0017446||Kano state
C0042210||vaccines
C1301808||state
C0475309||health centers
C0018017||objective
C0017446||Kano's
C0042210||vaccine
C0035363||retrospective review
C0017446||Kano's
C0042210||vaccine
C0376691||program
C0042210||vaccine
C0042210||vaccine
C0936012||Analysis
C0042196||vaccination trends
C0449416||in-sourced
C0449416||out-sourced
C0449445||approaches
C3161035||bottoms-up model-based approach
C0449416||out-sourced
C0449416||in-sourced
C0376691||programs
C0042210||vaccine
C0042196||vaccinations
C0042196||vaccinations
C0003320||antigens
C0003320||antigen
C0025007||measles
C0474232||Hepatitis b vaccinations
C0042196||vaccinations
C0020971||immunized
C0042210||vaccine
C0017446||Kano
C0243095||insourced
C0243095||outsourced
C0376691||programs
C0017446||Kano